| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.24 | 0.4 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |